F. Shojaiyan

Phase II study of adjuvant docetaxel and carboplatin with/without doxorubicin and cyclophosphamide in triple negative breast cancer: a randomised controlled clinical trial

S. Najafi, F. Abbasvandi, M. Payandeh, 2017, Contemporary oncology.

Phase III of Study of R-CHOP-21 vs R-CHOP-14 for Untreated Stage III and IV B-cell Non-Hodgkin's Lymphoma: a Report from Iran.

S. Najafi, M. Payandeh, M. Sadeghi, 2016, Asian Pacific journal of cancer prevention : APJCP.